Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GeneTEK: Low-power and high-performance FPGA scalable architecture for exact unit-cost edit distance.

Computers in biology and medicine·2026
Same author

The renewed role of interspinous devices: the InSpan system-a narrative review on surgical indications.

Journal of spine surgery (Hong Kong)·2026
Same author

Misconnected: Valve Failure from an Unexpected Chordal Insertion.

Portuguese journal of cardiac thoracic and vascular surgery·2026
Same author

Unmasking hepatopulmonary syndrome: the 6-min walk test as a key to a missed diagnosis.

BMJ case reports·2026
Same author

Tracheal Surgery - a 10-year Center Experience.

Portuguese journal of cardiac thoracic and vascular surgery·2025
Same author

Unseen Impact: A Bullet Lodged in an Unexpected Location.

Portuguese journal of cardiac thoracic and vascular surgery·2025

Related Experiment Video

Updated: May 28, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Non-cystic fibrosis bronchiectasis.

Paulo C Neves1, Miguel Guerra, Paulo Ponce

  • 1Department of Cardiothoracic Surgery, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal. pauloacn@gmail.com

Interactive Cardiovascular and Thoracic Surgery
|October 8, 2011
PubMed
Summary
This summary is machine-generated.

Bronchiectasis management for non-cystic fibrosis patients includes exercise, antibiotics, and surgery for severe cases. This review focuses on non-cystic fibrosis bronchiectasis treatment, differentiating it from cystic fibrosis care.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Experiment Videos

Last Updated: May 28, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Thoracic Surgery

Background:

  • Bronchiectasis involves irreversible airway widening, inflammation, and chronic infection.
  • Non-cystic fibrosis bronchiectasis (NCFB) management differs from cystic fibrosis (CF) cases.
  • Current treatments aim to improve quality of life and manage exacerbations.

Purpose of the Study:

  • To review current management strategies for NCFB.
  • To highlight differences in NCFB and CF management.
  • To emphasize the role of surgical intervention in NCFB.

Main Methods:

  • Literature review focusing on NCFB.
  • Comparison of NCFB and CF treatment protocols.
  • Analysis of evidence for exercise, antibiotics, and surgery in NCFB.

Main Results:

  • Exercise and inspiratory muscle training may enhance quality of life and endurance in NCFB.
  • Prolonged antibiotics show clinical benefits but limited impact on exacerbations or lung function.
  • Surgery is an option for localized, severe lung damage in NCFB patients.

Conclusions:

  • Management of NCFB requires tailored approaches, distinct from CF care.
  • Multimodal strategies including exercise, targeted antibiotics, and selective surgery are key.
  • Further research is needed to optimize NCFB treatment protocols.